Pfizer Inc
XHAM:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
XHAM:PFE
Watchlist
Price: 21.17 EUR -1.56% Market Closed
Market Cap: 120.4B EUR

Relative Value

The Relative Value of one PFE stock under the Base Case scenario is hidden EUR. Compared to the current market price of 21.17 EUR, Pfizer Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PFE Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
74
vs Industry
47
Median 3Y
2.4
Median 5Y
2.6
Industry
2.7
Forward
2.3
vs History
46
vs Industry
26
Median 3Y
13.2
Median 5Y
13.8
Industry
21.5
Forward
8
vs History
49
vs Industry
31
Median 3Y
11.8
Median 5Y
10.9
Industry
16.7
vs History
11
vs Industry
23
Median 3Y
11.7
Median 5Y
9.4
Industry
23
vs History
92
vs Industry
47
Median 3Y
1.7
Median 5Y
2
Industry
2.3
vs History
53
vs Industry
36
Median 3Y
2.9
Median 5Y
3
Industry
2.9
Forward
2.9
vs History
68
vs Industry
46
Median 3Y
4
Median 5Y
4.4
Industry
5.6
vs History
61
vs Industry
36
Median 3Y
7.6
Median 5Y
8
Industry
13.2
Forward
7.6
vs History
61
vs Industry
33
Median 3Y
10.4
Median 5Y
10.7
Industry
16.6
Forward
8.6
vs History
34
vs Industry
25
Median 3Y
14.2
Median 5Y
13
Industry
15.8
vs History
38
vs Industry
20
Median 3Y
19.1
Median 5Y
16
Industry
19
vs History
88
vs Industry
58
Median 3Y
1
Median 5Y
1.2
Industry
2

Multiples Across Competitors

PFE Competitors Multiples
Pfizer Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Pfizer Inc
XHAM:PFE
142.7B EUR 2.3 14.5 7.4 10.1
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.4 37.1 39.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
499.6B USD 5.4 19.9 16.3 21.1
CH
Roche Holding AG
SIX:ROG
262.5B CHF 4.3 27.8 11.9 13.9
UK
AstraZeneca PLC
LSE:AZN
212B GBP 4.9 30.5 108.5 158.8
CH
Novartis AG
SIX:NOVN
211.3B CHF 4.8 18.6 11.8 15.2
US
Merck & Co Inc
NYSE:MRK
265.6B USD 4.1 14 9.9 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.7 14.2 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
212.8B USD 91.8 -72.8 337 845
FR
Sanofi SA
PAR:SAN
99.3B EUR 1.5 7.2 6.6 6.6
P/E Multiple
Earnings Growth PEG
US
Pfizer Inc
XHAM:PFE
Average P/E: 22.4
14.5
27%
0.5
US
Eli Lilly and Co
NYSE:LLY
55.4
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.5
37%
0.8
CH
Novartis AG
SIX:NOVN
18.6
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.2
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -72.8 N/A N/A
FR
Sanofi SA
PAR:SAN
7.2
26%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Pfizer Inc
XHAM:PFE
Average EV/EBITDA: 400.2
7.4
0%
N/A
US
Eli Lilly and Co
NYSE:LLY
37.1
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.9
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.5
10%
10.9
CH
Novartis AG
SIX:NOVN
11.8
6%
2
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
1%
9.9
IE
E
Endo International PLC
LSE:0Y5F
337
N/A N/A
FR
Sanofi SA
PAR:SAN
6.6
8%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Pfizer Inc
XHAM:PFE
Average EV/EBIT: 1 712.4
10.1
7%
1.4
US
Eli Lilly and Co
NYSE:LLY
39.8
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.9
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.8
23%
6.9
CH
Novartis AG
SIX:NOVN
15.2
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
845
N/A N/A
FR
Sanofi SA
PAR:SAN
6.6
15%
0.4